Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 204, Issue 9, Pages 2015-2021Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20070841
Keywords
-
Categories
Funding
- NIAID NIH HHS [T32 AI007532, AI 042370, R01 AI061699, AI 061699, AI 071309, R01 AI042370, AI 007532, R01 AI071309] Funding Source: Medline
Ask authors/readers for more resources
Immunity to intracellular pathogens requires dynamic balance between terminal differentiation of short-lived, cytotoxic effector CD8(+) T cells and self-renewal of central-memory CD8(+) T cells. We now show that T-bet represses transcription of IL-7R alpha and drives differentiation of effector and effector-memory CD8(+) T cells at the expense of central-memory cells. We also found T-bet to be overexpressed in CD8(+) T cells that differentiated in the absence of CD4(+) T cell help, a condition that is associated with defective central-memory formation. Finally, deletion of T-bet corrected the abnormal phenotypic and functional properties of unhelped memory CD8(+) T cells. T-bet, thus, appears to function as a molecular switch between central-and effector-memory cell differentiation. Antagonism of T-bet may, therefore, represent a novel strategy to offset dysfunctional programming of memory CD8(+) T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available